new directions in immunotherapy for improving outcomes in tnbc
Published 1 year ago • 566 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:34
strategies to improve the response to immunotherapy in tnbc
-
1:22
immunological signatures to predict outcomes in patients with tnbc
-
3:28
immunotherapy in early-stage tnbc - where do we stand?
-
4:11
immunotherapy for tnbc: impassion130 & keynote-355
-
2:30
impassion130: immunotherapy for tnbc
-
1:15
challenges in tnbc
-
1:30
emerging immunotherapy beyond checkpoint inhibitors for tnbc
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
0:41
recent advances in targeted therapies for tnbc
-
1:15
clinical implications of progress in tnbc therapies
-
1:39
encouraging developments in triple negative breast cancer immunotherapy
-
5:49
immunotherapy for tnbc
-
13:27
treatment progress in tnbc – improving disparities and outcomes with new approaches
-
57:18
translating progress with immunotherapies and targeted agents into improved outcomes in tnbc
-
1:04
future directions in triple-negative breast cancer research
-
3:26
chemo-immunotherapy for tnbc
-
0:53
keynote-522 demonstrates potential for immunotherapy in triple-negative breast cancer
-
3:37
tnbc: immunotherapy in the neoadjuvant setting
-
5:41
future directions for treatment of tnbc